Rita Keynan

Corporate Officer/Principal bei PAINREFORM LTD.

Health Technology

Consumer Services

Aktive Positionen von Rita Keynan

Unternehmen	Position	Beginn	Ende
PAINREFORM LTD.	Corporate Officer/Principal	06.01.2021	-

Unternehmen	Position	Beginn	Ende
VYNE Pharmaceuticals Ltd. VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel.	Corporate Officer/Principal	-	-

The Hebrew University of Jerusalem

Graduate Degree

International

Israel

Operativ

Corporate Officer/Principal	2
Graduate Degree	1
Undergraduate Degree	1

Sektoral

Health Technology	3
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
PAINREFORM LTD.	Health Technology

Private Unternehmen	1
VYNE Pharmaceuticals Ltd. VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel.	Health Technology

Private Unternehmen

Health Technology